Tamas Constantin, Ph.D.
Affiliations: | 2009 | Semmelweis Egyetem, Hungary |
Area:
Medicine and SurgeryGoogle:
"Tamas Constantin"Parents
Sign in to add mentor| Peter Gergely | grad student | 2009 | Semmelweis Egyetem | |
| (A juvenilis dermatomyositis prognosztikai tenyezoinek vizsgalata.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brunner HI, Quartier P, Alexeeva E, et al. (2020) Efficacy and Safety of Canakinumab in sJIA Patients with and without Fever at Baseline: Results from an Open-label, Active Treatment Extension Study. Arthritis & Rheumatology (Hoboken, N.J.) |
| Foeldvari I, Klotsche J, Simonini G, et al. (2019) Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC). Pediatric Rheumatology Online Journal. 17: 66 |
| Mallalieu NL, Wimalasundera S, Hsu JC, et al. (2019) Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. Pediatric Rheumatology Online Journal. 17: 57 |
| Foeldvari I, Constantin T, Vojinović J, et al. (2019) Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Arthritis Research & Therapy. 21: 125 |
| Zulian F, Culpo R, Sperotto F, et al. (2019) Consensus-based recommendations for the management of juvenile localised scleroderma. Annals of the Rheumatic Diseases |
| Foeldvari I, Torok K, Ambartsumyan L, et al. (2019) Ab0966 Proposal Of Outcome Measures To Be Used On A 12-Month Open Label Drug Trial In Juvenile Systemic Sclerosis. Results Of The 3Rd Consensus Meeting In Hamburg December 2018 Annals of the Rheumatic Diseases. 78: 1949-1949 |
| Krol R, Swart JF, Giancane G, et al. (2019) Op0058 Development Of Inflammatory Bowel Disease During Treatment With Etanercept In Patientswith Juvenile Idiopathic Arthritis Annals of the Rheumatic Diseases. 78: 100-101 |
| Ruperto N, Brunner HI, Quartier P, et al. (2018) Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Annals of the Rheumatic Diseases |
| Orbán I, Constantin T, Dérfalvi B, et al. (2018) The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 38: 243-250 |
| Constantin T, Foeldvari I, Anton J, et al. (2018) Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Annals of the Rheumatic Diseases |